About Ranibizumab
            
            Class: | Monoclonal antibody (anti-VEGF)  
Use: | Treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), and myopic choroidal neovascularization (mCNV)  
Adult dose: | 0.5 mg (0.05 ml) injected intravitreally once a month; may be adjusted based on clinical response  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children  
Side effects: | C
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (anti-VEGF)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), and myopic choroidal neovascularization (mCNV)
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novartis Pharma AG, SWITZERLAND
                    
                    
                    Package Size
                    0.23ml Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5098.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        0.5 mg (0.05 ml) injected intravitreally once a month; may be adjusted based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include conjunctival hemorrhage, eye pain, increased intraocular pressure, and retinal detachment
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to ranibizumab or any component of the formulation; active ocular or periocular infection
         
        
        
            
                Important Warnings
            
            Risk of serious eye infections (endophthalmitis), retinal detachment, and increased intraocular pressure; monitor patients closely after injection
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Monoclonal antibody (anti-VEGF) medicines available in UAE pharmacies
            
            
            
                Brolucizumab
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.